218 related articles for article (PubMed ID: 26962236)
1. Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.
Mave V; Erlandson KM; Gupte N; Balagopal A; Asmuth DM; Campbell TB; Smeaton L; Kumarasamy N; Hakim J; Santos B; Riviere C; Hosseinipour MC; Sugandhavesa P; Infante R; Pillay S; Cardoso SW; Tripathy S; Mwelase N; Berendes S; Andrade BB; Thomas DL; Bollinger RC; Gupta A;
J Infect Dis; 2016 Jul; 214(1):65-72. PubMed ID: 26962236
[TBL] [Abstract][Full Text] [Related]
2. Weight change after antiretroviral therapy and mortality.
Yuh B; Tate J; Butt AA; Crothers K; Freiberg M; Leaf D; Logeais M; Rimland D; Rodriguez-Barradas MC; Ruser C; Justice AC
Clin Infect Dis; 2015 Jun; 60(12):1852-9. PubMed ID: 25761868
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated With Being Overweight and Obesity in People Living With Human Immunodeficiency Virus on Antiretroviral Therapy: Socioclinical, Inflammation, and Metabolic Markers.
Goupil de Bouillé J; Vigouroux C; Plessis L; Ghislain M; Teglas JP; Boufassa F; Goujard C; Vignes D; Bouchaud O; Salmon D; Meyer L; Abgrall S;
J Infect Dis; 2021 Nov; 224(9):1570-1580. PubMed ID: 33740044
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.
Guehi C; Badjé A; Gabillard D; Ouattara E; Koulé SO; Moh R; Ekouevi D; Ahibo H; N'Takpé JB; Menan GK; Deschamps N; Lecarrou J; Eholié S; Anglaret X; Danel C
AIDS Res Ther; 2016; 13():12. PubMed ID: 26925155
[TBL] [Abstract][Full Text] [Related]
5. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.
Achhra AC; Mocroft A; Reiss P; Sabin C; Ryom L; de Wit S; Smith CJ; d'Arminio Monforte A; Phillips A; Weber R; Lundgren J; Law MG;
HIV Med; 2016 Apr; 17(4):255-68. PubMed ID: 26216031
[TBL] [Abstract][Full Text] [Related]
6. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
[TBL] [Abstract][Full Text] [Related]
7. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
8. Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy.
Koethe JR; Dee K; Bian A; Shintani A; Turner M; Bebawy S; Sterling TR; Hulgan T
AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1019-25. PubMed ID: 23469772
[TBL] [Abstract][Full Text] [Related]
9. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.
Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD;
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):50-8. PubMed ID: 26352511
[TBL] [Abstract][Full Text] [Related]
10. HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.
Bares SH; Smeaton LM; Xu A; Godfrey C; McComsey GA
J Womens Health (Larchmt); 2018 Sep; 27(9):1162-1169. PubMed ID: 29608129
[TBL] [Abstract][Full Text] [Related]
11. Postpartum obesity and weight gain among human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women in South Africa.
Bengtson AM; Phillips TK; le Roux SM; Brittain K; Buba A; Abrams EJ; Myer L
Matern Child Nutr; 2020 Jul; 16(3):e12949. PubMed ID: 31943774
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study.
Sharma A; Hoover DR; Shi Q; Gustafson D; Plankey MW; Hershow RC; Tien PC; Golub ET; Anastos K
PLoS One; 2015; 10(12):e0143740. PubMed ID: 26699870
[TBL] [Abstract][Full Text] [Related]
13. A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy.
Canipe A; Chidumayo T; Blevins M; Bestawros M; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
BMC Infect Dis; 2014 Sep; 14():521. PubMed ID: 25266928
[TBL] [Abstract][Full Text] [Related]
14. Weight status and associated factors among HIV infected people on antiretroviral therapy in rural Dikgale, Limpopo, South Africa.
Mashinya F; Alberts M; Colebunders R; Van Geertruyden JP
Afr J Prim Health Care Fam Med; 2016 Nov; 8(1):e1-e8. PubMed ID: 28155318
[TBL] [Abstract][Full Text] [Related]
15. Growth in HIV-infected children on long-term antiretroviral therapy.
Feucht UD; Van Bruwaene L; Becker PJ; Kruger M
Trop Med Int Health; 2016 May; 21(5):619-29. PubMed ID: 26914715
[TBL] [Abstract][Full Text] [Related]
16. HIV infection and obesity: where did all the wasting go?
Tate T; Willig AL; Willig JH; Raper JL; Moneyham L; Kempf MC; Saag MS; Mugavero MJ
Antivir Ther; 2012; 17(7):1281-9. PubMed ID: 22951353
[TBL] [Abstract][Full Text] [Related]
17. Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study.
La Rosa AM; Harrison LJ; Taiwo B; Wallis CL; Zheng L; Kim P; Kumarasamy N; Hosseinipour MC; Jarocki B; Mellors JW; Collier AC;
Lancet HIV; 2016 Jun; 3(6):e247-58. PubMed ID: 27240787
[TBL] [Abstract][Full Text] [Related]
18. Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons.
Lakey W; Yang LY; Yancy W; Chow SC; Hicks C
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):435-40. PubMed ID: 23072344
[TBL] [Abstract][Full Text] [Related]
19. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.
Li X; Ding H; Geng W; Liu J; Jiang Y; Xu J; Zhang Z; Shang H
BMC Infect Dis; 2019 May; 19(1):373. PubMed ID: 31046702
[TBL] [Abstract][Full Text] [Related]
20. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.
Banerjee T; Pensi T; Banerjee D; Grover G
Ann Trop Paediatr; 2010; 30(1):27-37. PubMed ID: 20196931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
